Literature DB >> 2786436

Long-term growth of malignant thymocytes in vitro.

S D Smith1, P McFall, R Morgan, M Link, F Hecht, M Cleary, J Sklar.   

Abstract

We report a new methodology for the long-term growth of malignant T-lymphoblasts from patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LL). When malignant cells were cultured in the presence of insulin-like growth factor I under hypoxic conditions, cellular proliferation occurred that resulted in the establishment of immortal cell lines from ten of 12 patient tumors. Authenticity of each cell line was verified by a direct comparison of the immunophenotype, karyotype, and immunogenotype with the patient's tumor cells. This improved method of cell culture permits frequent establishment of cell lines from patients with T-ALL/T-LL, thereby aiding in analysis of thymocyte transformation and neoplasia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786436

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms.

Authors:  A Bourguin; R Tung; N Galili; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias.

Authors:  S Ziemin-van der Poel; N R McCabe; H J Gill; R Espinosa; Y Patel; A Harden; P Rubinelli; S D Smith; M M LeBeau; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia.

Authors:  K L Mohnike; U Kluba; U Mittler; V Aumann; P Vorwerk; W F Blum
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

4.  The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed.

Authors:  Y Laabi; M P Gras; J C Brouet; R Berger; C J Larsen; A Tsapis
Journal:  Nucleic Acids Res       Date:  1994-04-11       Impact factor: 16.971

5.  Identification of the TCL1 gene involved in T-cell malignancies.

Authors:  L Virgilio; M G Narducci; M Isobe; L G Billips; M D Cooper; C M Croce; G Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif.

Authors:  C G Begley; P D Aplan; S M Denning; B F Haynes; T A Waldmann; I R Kirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.

Authors:  J Yeargin; J Cheng; A L Yu; R Gjerset; M Bogart; M Haas
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations.

Authors:  N R McCabe; R C Burnett; H J Gill; M J Thirman; D Mbangkollo; M Kipiniak; E van Melle; S Ziemin-van der Poel; J D Rowley; M O Diaz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Mobilization of intracellular Ca2+ by adenine nucleotides in human T-leukaemia cells: evidence for ADP-specific and P2y-purinergic receptors.

Authors:  M Biffen; D R Alexander
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

10.  Next-generation NAMPT inhibitors identified by sequential high-throughput phenotypic chemical and functional genomic screens.

Authors:  Christina J Matheny; Michael C Wei; Michael C Bassik; Alicia J Donnelly; Martin Kampmann; Masayuki Iwasaki; Obdulio Piloto; David E Solow-Cordero; Donna M Bouley; Rachel Rau; Patrick Brown; Michael T McManus; Jonathan S Weissman; Michael L Cleary
Journal:  Chem Biol       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.